COMBINATION THERAPY OF TUMOR-TARGETED IL-2 VARIANT IMMUNOCYTOKINES AND ANTIBODIES AGAINST HUMAN PD-L1

• 收藏
• 分享

专利权人:

Hoffmann-La Roche Inc.

发明人:

Pablo Umana,Christian Klein,Valeria G. Nicolini

申请号：

US15851253

公开号：

US20180200338A1

申请日:

2017.12.21

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present invention relates to the combination therapy of specific tumor-targeted IL-2 variant immunocytokines with specific antibodies which bind human PD-L1.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/